Advances and challenges in immunotherapy for solid organ and hematopoietic stem cell transplantation

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Science Translational Medicine

• Publication date

  2015-03-25

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1126/scitranslmed.aaa6853PMID 25810312PMCID PMC4425354
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Hallmarks of Cancer Cell

  2017cited by this paper
• Blockade of CD40–CD154 Costimulatory Pathway Promotes Long‐Term Survival of Full‐Thickness Porcine Corneal Grafts in Nonhuman Primates: Clinically Applicable Xenocorneal Transplantation

  2015cited by this paper
• Tracking donor-reactive T cells: Evidence for clonal deletion in tolerant kidney transplant patients

  2015cited by this paper
• Histone deacetylase inhibition regulates inflammation and enhances Tregs after allogeneic hematopoietic cell transplantation in humans.

  2015cited by this paper
• Therapeutic activity of multiple common γ-chain cytokine inhibition in acute and chronic GVHD.

  2015cited by this paper
• Use of compositions modulating chromatin structure for graft versus host disease (gvhd)

  2015cited by this paper
• The Rho Kinases: Critical Mediators of Multiple Profibrotic Processes and Rational Targets for New Therapies for Pulmonary Fibrosis

  2015cited by this paper
• A prognostic score for acute graft-versus-host disease based on biomarkers: a multicentre study.

  2015cited by this paper
• IL-6 inhibitors for treatment of rheumatoid arthritis: past, present, and future

  2015cited by this paper
• The chromatin-modifying enzyme Ezh2 is critical for the maintenance of regulatory T cell identity after activation.

  2015cited by this paper
• Immunomodulation effects of mesenchymal stromal cells on acute graft-versus-host disease after hematopoietic stem cell transplantation.

  2015cited by this paper
• Ibrutinib treatment ameliorates murine chronic graft-versus-host disease.

  2014cited by this paper
• Acute graft-versus-host disease: a bench-to-bedside update.

  2014cited by this paper
• HLA-haploidentical transplantation with regulatory and conventional T-cell adoptive immunotherapy prevents acute leukemia relapse.

  2014cited by this paper
• Administration of anti-CD20 mAb is highly effective in preventing but ineffective in treating chronic graft-versus-host disease while preserving strong graft-versus-leukemia effects.

  2014cited by this paper
• Donor CD4 T Cells Trigger Costimulation Blockade‐Resistant Donor Bone Marrow Rejection Through Bystander Activation Requiring IL‐6

  2014cited by this paper
• Plasma CXCL9 elevations correlate with chronic GVHD diagnosis.

  2014cited by this paper
• Therapeutic benefit of bortezomib on acute graft-versus-host disease is tissue specific and is associated with interleukin-6 levels.

  2014influential reference
• Regulatory dendritic cell therapy: from rodents to clinical application.

  2014cited by this paper
• Increased T follicular helper cells and germinal center B cells are required for cGVHD and bronchiolitis obliterans.

  2014cited by this paper
• Therapeutic activity of multiple common gamma chain cytokine inhibition in acute and chronic GvHD

  2014cited by this paper
• Addition of interleukin-6 inhibition with tocilizumab to standard graft-versus-host disease prophylaxis after allogeneic stem-cell transplantation: a phase 1/2 trial.

  2014cited by this paper
• Activity of therapeutic JAK 1/2 blockade in graft-versus-host disease.

  2014cited by this paper
• Multi-institutional study of post-transplantation cyclophosphamide as single-agent graft-versus-host disease prophylaxis after allogeneic bone marrow transplantation using myeloablative busulfan and fludarabine conditioning.

  2014cited by this paper
• Vorinostat plus tacrolimus and mycophenolate to prevent graft-versus-host disease after related-donor reduced-intensity conditioning allogeneic haemopoietic stem-cell transplantation: a phase 1/2 trial.

  2014cited by this paper
• The biology of graft-versus-host disease: experimental systems instructing clinical practice.

  2014cited by this paper
• Itk-mediated integration of T cell receptor and cytokine signaling regulates the balance between Th17 and regulatory T cells

  2014cited by this paper
• Mesenchymal stem cell therapy and acute graft-versus-host disease: a review

  2014cited by this paper
• Small-molecule RORγt antagonists inhibit T helper 17 cell transcriptional network by divergent mechanisms.

  2014cited by this paper
• A phase II study of bortezomib plus prednisone for initial therapy of chronic graft-versus-host disease.

  2014cited by this paper
• Treatment of chronic graft-versus-host disease with bortezomib.

  2014cited by this paper
• Ibrutinib versus ofatumumab in previously treated chronic lymphoid leukemia.

  2014cited by this paper
• Current issues in chronic graft-versus-host disease.

  2014cited by this paper
• Vascular Endothelium as a Target of Immune Response in Renal Transplant Rejection

  2014cited by this paper
• Selective oral ROCK2 inhibitor down-regulates IL-21 and IL-17 secretion in human T cells via STAT3-dependent mechanism

  2014cited by this paper
• Coexpression of CD49b and LAG-3 identifies human and mouse T regulatory type 1 cells

  2013cited by this paper
• Ibrutinib is an irreversible molecular inhibitor of ITK driving a Th1-selective pressure in T lymphocytes.

  2013cited by this paper
• ST2 as a marker for risk of therapy-resistant graft-versus-host disease and death.

  2013cited by this paper
• Germinal center dysregulation by histone methyltransferase EZH2 promotes lymphomagenesis.

  2013cited by this paper
• Immunological Outcome in Haploidentical-HSC Transplanted Patients Treated with IL-10-Anergized Donor T Cells

  2013cited by this paper
• Efficacy, safety, and survival with ruxolitinib in patients with myelofibrosis: results of a median 3-year follow-up of COMFORT-I

  2013cited by this paper
• B-cell targeted therapeutics in clinical development

  2013cited by this paper
• Pharmacologic inhibition of PKCα and PKCθ prevents GVHD while preserving GVL activity in mice.

  2013influential reference
• Rituximab prophylaxis prevents corticosteroid-requiring chronic GVHD after allogeneic peripheral blood stem cell transplantation: results of a phase 2 trial.

  2013cited by this paper
• An inherently bifunctional subset of Foxp3+ T helper cells is controlled by the transcription factor eos.

  2013cited by this paper
• B-Cell-Mediated Strategies to Fight Chronic Allograft Rejection

  2013cited by this paper
• Signaling through C5a receptor and C3a receptor diminishes function of murine natural regulatory T cells

  2013cited by this paper
• Signaling through C 5 a receptor and C 3 a receptor diminishes function of murine natural regulatory T cells

  2013cited by this paper
• Research Highlights and Editors’ Picks

  2013influential reference
• Aldehyde Dehydrogenase Expression Drives Human Regulatory T Cell Resistance to Posttransplantation Cyclophosphamide

  2013cited by this paper
• Alterations in Chemokine Receptor CCR5 Expression on Blood Dendritic Cells Correlate With Acute Graft-Versus-Host Disease

  2013cited by this paper
• Antagonist properties of monoclonal antibodies targeting human CD28

  2013cited by this paper
• In vivo T cell costimulation blockade with abatacept for acute graft-versus-host disease prevention: a first-in-disease trial.

  2013cited by this paper
• The histone methyltransferase Ezh 2 is a crucial epigenetic regulator of allogeneic T-cell responses mediating graft-versus-host disease

  2013cited by this paper
• Efficacy of Sotrastaurin Plus Tacrolimus After De Novo Kidney Transplantation: Randomized, Phase II Trial Results

  2013cited by this paper
• The histone methyltransferase Ezh2 is a crucial epigenetic regulator of allogeneic T-cell responses mediating graft-versus-host disease.

  2013cited by this paper
• Development and maintenance of regulatory T cells.

  2013cited by this paper
• Low-Dose Interleukin-2 Therapy Restores Regulatory T Cell Homeostasis in Patients with Chronic Graft-Versus-Host Disease

  2013cited by this paper
• Efficacy and safety of ustekinumab in patients with active psoriatic arthritis: 1 year results of the phase 3, multicentre, double-blind, placebo-controlled PSUMMIT 1 trial.

  2013cited by this paper
• Blockade of Lymphocyte Chemotaxis in Visceral Graft-Versus-Host Disease

  2013cited by this paper
• HLA-mismatched renal transplantation without maintenance immunosuppression.

  2013cited by this paper
• The mesenchymal stromal cells dilemma--does a negative phase III trial of random donor mesenchymal stromal cells in steroid-resistant graft-versus-host disease represent a death knell or a bump in the road?

  2013cited by this paper
• Rituximab in renal transplantation

  2013cited by this paper
• Advances in graft-versus-host disease biology and therapy

  2012cited by this paper
• The hallmarks of cancer

  2012cited by this paper
• Blockade of lymphocyte chemotaxis in visceral graft-versus-host disease.

  2012cited by this paper
• Azacitidine augments expansion of regulatory T cells after allogeneic stem cell transplantation in patients with acute myeloid leukemia (AML).

  2012influential reference
• Ustekinumab demonstrates activity in glucocorticoid-refractory acute GVHD

  2012cited by this paper
• Preclinical Efficacy and Immunological Safety of FR104, an Antagonist Anti‐CD28 Monovalent Fab′ Antibody

  2012cited by this paper
• Post-transplantation cyclophosphamide for tolerance induction in HLA-haploidentical bone marrow transplantation.

  2012cited by this paper
• Relevance of regulatory T cell promotion of donor-specific tolerance in solid organ transplantation

  2012cited by this paper
• Prophylactic rituximab after allogeneic transplantation decreases B-cell alloimmunity with low chronic GVHD incidence.

  2012cited by this paper
• Acute graft-versus-host disease biomarkers measured during therapy can predict treatment outcomes: a Blood and Marrow Transplant Clinical Trials Network study.

  2012cited by this paper
• Chimerism and Tolerance Without GVHD or Engraftment Syndrome in HLA-Mismatched Combined Kidney and Hematopoietic Stem Cell Transplantation

  2012cited by this paper
• The impact of donor-specific anti-HLA antibodies on late kidney allograft failure

  2012cited by this paper
• Randomized Phase 2b Trial of Tofacitinib (CP‐690,550) in De Novo Kidney Transplant Patients: Efficacy, Renal Function and Safety at 1 Year

  2012cited by this paper
• A Need for Biomarkers of Operational Tolerance in Liver and Kidney Transplantation

  2012cited by this paper
• Infusion of ex vivo expanded T regulatory cells in adults transplanted with umbilical cord blood: safety profile and detection kinetics.

  2011cited by this paper
• IMMUNOLOGICAL CONSEQUENCES AND TRAFFICKING OF HUMAN REGULATORY MACROPHAGES ADMINISTERED TO RENAL TRANSPLANT RECIPIENTS

  2011cited by this paper
• Cutting Edge: Immunological Consequences and Trafficking of Human Regulatory Macrophages Administered to Renal Transplant Recipients

  2011cited by this paper
• Long-term survival and late deaths after allogeneic hematopoietic cell transplantation.

  2011cited by this paper
• Sequential activation of inflammatory signaling pathways during graft-versus-host disease (GVHD): early role for STAT1 and STAT3.

  2011cited by this paper
• IL-6 Promotes Cardiac Graft Rejection Mediated by CD4+ Cells

  2011cited by this paper
• Bruton tyrosine kinase represents a promising therapeutic target for treatment of chronic lymphocytic leukemia and is effectively targeted by PCI-32765.

  2011cited by this paper
• Rapamycin and IL-2 reduce lethal acute graft-versus-host disease associated with increased expansion of donor type CD4+CD25+Foxp3+ regulatory T cells.

  2011cited by this paper
• Rejection of the kidney allograft.

  2010cited by this paper
• Identification of a B cell signature associated with renal transplant tolerance in humans.

  2010cited by this paper
• Development of a cross-platform biomarker signature to detect renal transplant tolerance in humans.

  2010cited by this paper
• Interleukin-6 Modulates Graft-versus-Host Responses after Experimental Allogeneic Bone Marrow Transplantation

  2010cited by this paper
• Abrogation of donor T-cell IL-21 signaling leads to tissue-specific modulation of immunity and separation of GVHD from GVL.

  2010cited by this paper
• In vivo administration of hypomethylating agents mitigate graft-versus-host disease without sacrificing graft-versus-leukemia.

  2010influential reference
• ECULIZUMAB PREVENTS RECURRENCE OF ANTIPHOSPHOLIPID ANTIBODY SYNDROME (APS) IN RENAL ALLOGRAFTS: 2791

  2010cited by this paper
• A small-molecule inhibitor of BCL6 kills DLBCL cells in vitro and in vivo.

  2010cited by this paper
• Phosphorylation of IRF4 by ROCK2 regulates IL-17 and IL-21 production and the development of autoimmunity in mice.

  2010cited by this paper
• Reduced mortality after allogeneic hematopoietic-cell transplantation.

  2010cited by this paper
• Preemptive CD20+ B cell depletion attenuates cardiac allograft vasculopathy in cyclosporine-treated monkeys.

  2010cited by this paper
• Role of T cells in graft rejection and transplantation tolerance

  2010cited by this paper
• Mesenchymal stem cell as salvage treatment for refractory chronic GVHD

  2010cited by this paper
• Bortezomib as the Sole Post‐Renal Transplantation Desensitization Agent Does Not Decrease Donor‐Specific Anti‐HLA Antibodies

  2010cited by this paper
• Blockade of interleukin-23 signaling results in targeted protection of the colon and allows for separation of graft-versus-host and graft-versus-leukemia responses.

  2009cited by this paper

• Kinetics of De Novo Bone and Bone Marrow Niche Formation With Hybrid Click Cryogels.

  2026cites this paper
• Acetyl-CoA carboxylase 1 inhibition increases Treg metabolism and graft-versus-host disease treatment efficacy via mitochondrial fusion

  2025cites this paper
• Allogeneic Stem Cell Transplantation: Current Status and Future Directions

  2025cites this paper
• HLA-A2 CAR/IL-2-CISC engineered Treg display robust in vitro and in vivo antigen-specific regulatory function

  2025cites this paper
• A humanized IL-2 mutein expands Tregs and prolongs transplant survival in preclinical models

  2024cites this paper
• Rapamycin Liposomes Targeted to Lymph Nodes Inhibit Dendritic Cell Maturation for the Treatment of Transplant Rejection

  2024cites this paper
• Immune isolation-enabled nanoencapsulation of donor T cells: a promising strategy for mitigating GVHD and treating AML in preclinical models

  2024cites this paper
• The roles of epigenetic regulation in graft-versus-host disease.

  2024cites this paper
• RORγt inverse agonist TF-S14 inhibits Th17 cytokines and prolongs skin allograft survival in sensitized mice

  2024cites this paper
• A novel FK506-loading mesoporous silica nanoparticle homing to lymph nodes for transplant rejection treatment.

  2024cites this paper
• Plasma Cell-Free RNA Captures Immune Dynamics and Predicts GVHD after Hematopoietic Stem Cell Transplantation

  2024cites this paper
• Enhanced Proliferation of Visualizable Mesenchymal Stem Cell-Platelet Hybrid Cell for Versatile Intracerebral Hemorrhage Treatment.

  2023cites this paper
• Complex interactions of cellular players in chronic Graft-versus-Host Disease

  2023cites this paper
• The Present Condition of Sickle Cell Disease: An Overview of Stem Cell Transplantation as a Cure

  2023cites this paper
• mTORC1 Inhibition Protects Human Regulatory T Cells From Granzyme-B-Induced Apoptosis

  2022cites this paper
• Cell-free DNA profiling informs all major complications of hematopoietic cell transplantation

  2022cites this paper
• Donor whole blood DNA methylation is not a strong predictor of acute graft versus host disease in unrelated donor allogeneic haematopoietic cell transplantation

  2022cites this paper
• Emerging local immunomodulatory strategies to circumvent systemic immunosuppression in cell transplantation

  2022influential citation
• Development of Cell Therapies for Renal Disease and Regenerative Medicine

  2022cites this paper
• Engineering of hybrid spheroids of mesenchymal stem cells and drug depots for immunomodulating effect in islet xenotransplantation

  2022cites this paper
• Mannan binding lectin promotes murine graft versus host disease by amplifying lipopolysaccharide-initiated inflammation.

  2022cites this paper
• COVID-19 in immunocompromised patients: A systematic review of cancer, hematopoietic cell and solid organ transplant patients

  2021cites this paper
• Bone Marrow Regulatory T Cells Are a Unique Population, Supported by Niche-Specific Cytokines and Plasmacytoid Dendritic Cells, and Required for Chronic Graft-Versus-Host Disease Control

  2021cites this paper
• XBP-1s Promotes B Cell Pathogenicity in Chronic GVHD by Restraining the Activity of Regulated IRE-1α-Dependent Decay

  2021cites this paper
• Process development and validation of expanded regulatory T cells for prospective applications: an example of manufacturing a personalized advanced therapy medicinal product

  2021cites this paper
• Donor Macrophages Modulate Rejection after Heart Transplantation

  2021cites this paper
• Application of Immune Checkpoint Inhibitors in Solid Organ Transplantation Recipients: A Systematic Review

  2021cites this paper
• Interleukin‐23 receptor signaling by interleukin‐39 potentiates T cell pathogenicity in acute graft‐versus‐host disease

  2021cites this paper
• Multiply restimulated human thymic regulatory T cells express distinct signature regulatory T-cell transcription factors without evidence of exhaustion.

  2021cites this paper
• Review of the immune mechanisms of preeclampsia and the potential of immune modulating therapy.

  2021cites this paper
• Reconstitution of Circulating Mucosal-Associated Invariant T Cells after Allogeneic Hematopoietic Cell Transplantation: Its Association with the Riboflavin Synthetic Pathway of Gut Microbiota in Cord Blood Transplant Recipients

  2020cites this paper
• Regulatory T cells engineered with TCR signaling–responsive IL-2 nanogels suppress alloimmunity in sites of antigen encounter

  2020cites this paper
• Modulating the wayward T cell: New horizons with immune checkpoint inhibitor treatments in autoimmunity, transplant, and cancer.

  2020cites this paper
• Cellular and molecular profiling of T-cell subsets at the onset of human acute GVHD.

  2020cites this paper
• A rapid, sensitive, and reproducible in vivo PBMC humanized murine model for determining therapeutic‐related cytokine release syndrome

  2020cites this paper
• Cell-free DNA Tissues-of-Origin Profiling to Predict Graft versus Host Disease and Detect Infection after Hematopoietic Cell Transplantation

  2020cites this paper
• Noninvasive Tracking of Hematopoietic Stem Cells in a Bone Marrow Transplant Model

  2020cites this paper
• Cell-free DNA Profiling Informs Major Complications of Hematopoietic Cell Transplantation

  2020cites this paper
• Pathophysiology and Management of Graft-Versus-Host Disease

  2019cites this paper
• T memory stem cells after allogeneic haematopoietic cell transplantation: unique long‐term kinetics and influence of chronic graft‐versus‐host disease

  2019cites this paper
• Temporary Reduction of Membrane CD4 with the Antioxidant MnTBAP Is Sufficient to Prevent Immune Responses Induced by Gene Transfer

  2019cites this paper
• A late B lymphocyte action in dysfunctional tissue repair following kidney injury and transplantation

  2019cites this paper
• Targeting PI3Kδ function for amelioration of murine chronic graft‐versus‐host disease

  2019cites this paper
• Outcomes of total hip arthroplasty surgery in heart and lung transplant recipients

  2019cites this paper
• The IL-12 Cytokine and Receptor Family in Graft-vs.-Host Disease

  2019cites this paper
• Consensus recommendations for the role and competencies of the EBMT clinical pharmacist and clinical pharmacologist involved in hematopoietic stem cell transplantation

  2019cites this paper
• Organ Transplantation: An Overview from History to Challenges

  2018cites this paper
• Peripheral blood detection of systemic graft-specific xeno-antibodies following transplantation of human neural progenitor cells into the porcine spinal cord.

  2018cites this paper
• Impaired Secretion of TNF-&agr; by Monocytes Stimulated With EBV Peptides Associates With Infectious Complications After Kidney Transplantation

  2018cites this paper
• Multipotent Adult Progenitor Cells Suppress T Cell Activation in In Vivo Models of Homeostatic Proliferation in a Prostaglandin E2-Dependent Manner

  2018cites this paper
• Utility of IL-2 Complexes in Promoting the Survival of Murine Orthotopic Forelimb Vascularized Composite Allografts

  2018cites this paper
• The vimentin intermediate filament network restrains regulatory T cell suppression of graft-versus-host disease

  2018cites this paper
• Interferon regulatory factors: Where to stand in transplantation.

  2018cites this paper
• C5aR1 regulates T follicular helper differentiation and chronic graft-versus-host disease bronchiolitis obliterans.

  2018cites this paper
• Late B lymphocyte action in dysfunctional tissue repair following kidney injury and transplantation

  2018cites this paper
• Chronic graft-versus-host disease: biological insights from preclinical and clinical studies.

  2017cites this paper
• Fibroblastic niches prime T cell alloimmunity through Delta-like Notch ligands

  2017cites this paper
• Pirfenidone ameliorates murine chronic GVHD through inhibition of macrophage infiltration and TGF-β production.

  2017cites this paper
• Awards in Transplantation Science Recognize the Best Articles Published in Transplantation.

  2017cites this paper
• Precision monitoring of immunotherapies in solid organ and hematopoietic stem cell transplantation

  2017cites this paper
• Altered homeostatic regulation of innate and adaptive immunity in lower gastrointestinal tract GVHD pathogenesis

  2017cites this paper
• Optimization of cGMP purification and expansion of umbilical cord blood-derived T-regulatory cells in support of first-in-human clinical trials.

  2017cites this paper
• Preserved Liver Transplant After PD-1 Pathway Inhibitor for Hepatocellular Carcinoma

  2017cites this paper
• Alarmins and Their Receptors as Modulators and Indicators of Alloimmune Responses

  2017cites this paper
• Regulatory T Lymphocytes (Treg): Modulation and Clinical Application

  2017cites this paper
• A PET Imaging Strategy to Visualize Activated T Cells in Acute Graft-versus-Host Disease Elicited by Allogenic Hematopoietic Cell Transplant.

  2017cites this paper
• Preclinical modeling of hematopoietic stem cell transplantation – advantages and limitations

  2016cites this paper
• Induction of Major Histocompatibility Complex-mismatched Mouse Lung Allograft Acceptance With Combined Donor Bone Marrow: Lung Transplant Using a 12-Hour Nonmyeloablative Conditioning Regimen

  2016cites this paper
• Advances in understanding the pathogenesis of graft‐versus‐host disease

  2016cites this paper
• The role of regulatory B cells (Bregs) in the Tregs-amplifying effect of Sirolimus.

  2016cites this paper
• What is wrong with the regulatory T cells and foetomaternal tolerance in women with recurrent miscarriages?

  2016cites this paper
• Graft Versus Host Disease After Liver Transplantation in Adults: A Case series, Review of Literature, and an Approach to Management

  2016cites this paper
• How Do Previous Solid Organ Transplant Recipients Fare After Primary Total Knee Arthroplasty?

  2016cites this paper
• Therapeutic regulatory T-cell adoptive transfer ameliorates established murine chronic GVHD in a CXCR5-dependent manner.

  2016cites this paper
• The Importance of Positive Immunomagnetic Cell Separation Prior to Autologous Hematopoetic Stem Cell Transplantation for Advanced Stage Lymphomas

  2016cites this paper
• Series CHRONIC GRAFT-VERSUS-HOST DISEASE Chronic graft-versus-host disease : biological insights from preclinical and clinical studies

  2016cites this paper
• Adoptive Cell Therapy with Tregs to Improve Transplant Outcomes: the Promise and the Stumbling Blocks

  2016cites this paper
• Preclinical testing of anti-human CD28 Fab' antibody in a novel nonhuman primate (NHP) small animal rodent model of xenogenic graft-versus-host disease (GVHD).

  2016cites this paper
• Systems analysis uncovers inflammatory Th/Tc17-driven modules during acute GVHD in monkey and human T cells.

  2016cites this paper
• Vaccination of special populations: Protecting the vulnerable.

  2016cites this paper
• Regulatory T Cell Infusion Can Enhance Memory T Cell and Alloantibody Responses in Lymphodepleted Nonhuman Primate Heart Allograft Recipients

  2016cites this paper
• Awards in Transplantation Science Recognize the Best Manuscripts Published in Transplantation.

  2016cites this paper
• Controlling the burn and fueling the fire: defining the role for the alarmin interleukin-33 in alloimmunity

  2016cites this paper
• The Journal of Clinical Investigation

  2016cites this paper
• Programmed death ligand-1 expression on donor T cells drives graft-versus-host disease lethality.

  2016cites this paper
• Interleukin-33 in health and disease

  2016cites this paper
• Preclinical Testing of Antihuman CD28 Fab′ Antibody in a Novel Nonhuman Primate Small Animal Rodent Model of Xenogenic Graft-Versus-Host Disease

  2016cites this paper
• Peri-alloHCT IL-33 administration expands recipient T-regulatory cells that protect mice against acute GVHD.

  2016cites this paper
• High-throughput Functional Genomics Identifies Regulators of Primary Human Beta Cell Proliferation*

  2016cites this paper
• Immune Tolerance in Hemopoietic Stem Cell Transplantation

  2016cites this paper
• Exploring cell-based tolerance strategies for hand and face transplantation

  2015cites this paper
• The Influence of Immunosuppressive Agents on the Risk of De Novo Donor-Specific HLA Antibody Production in Solid Organ Transplant Recipients

  2015cites this paper
• Mathematical Modeling of Early Cellular Innate and Adaptive Immune Responses to Ischemia/Reperfusion Injury and Solid Organ Allotransplantation

  2015cites this paper
• A donor-specific epigenetic classifier for acute graft-versus-host disease severity in hematopoietic stem cell transplantation

  2015cites this paper
• Regenerative Medicine Build-Out

  2015cites this paper
• Tolerogenic Dendritic Cells on Transplantation: Immunotherapy Based on Second Signal Blockage

  2015cites this paper
• Perspective: Dendrimer drugs for infection and inflammation.

  2015cites this paper
• Trial Watch: Adoptive cell transfer for oncological indications

  2015cites this paper
• Mediterranean Journal of Hematology and Infectious Diseases the Gut Microbiota and Immune System Relationship in Human Graft-versus-host Disease

  year unknowncites this paper